UPDATED Sep 23, 2025
Discover large cap Norwegian Pharmaceuticals & Biotech companies that are on the OSEAX. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
PHO | NOK 57.40 | -4.0% | 8.7% | NOK 1.5b | NOK 82.50 | PS2.9x | E120.4% | 0% | ||
AZT | NOK 25.50 | 1.6% | 45.1% | NOK 1.3b | NOK 29.00 | PE464.6x | E79.5% | n/a | ||
TRMED | NOK 3.60 | -23.1% | 253.1% | NOK 1.3b | n/a | PS12689.8x | n/a | n/a | ||
VISTN | NOK 23.10 | -1.3% | -17.2% | NOK 1.0b | n/a | PE13.5x | n/a | 5.4% | ||
HBC | NOK 1.75 | -2.8% | 1.7% | NOK 682.4m | n/a | PS2.7x | n/a | n/a | ||
NYKD | NOK 1.58 | 5.5% | -66.0% | NOK 522.5m | NOK 8.50 | PS6.6x | E-7.2% | 60.1% | ||
LYTIX | NOK 7.20 | -6.3% | -2.2% | NOK 480.6m | NOK 13.00 | PS808.4x | S205.0% | n/a | ||
NORD | NOK 81.00 | 0% | 95.2% | NOK 415.7m | n/a | PE3.3x | n/a | 0% | ||
NAVA | NOK 21.50 | -1.4% | -28.6% | NOK 383.3m | NOK 36.00 | PB1.8x | E108.2% | n/a | ||
ZLNA | NOK 12.30 | -3.1% | n/a | NOK 255.7m | n/a | PS4746.9x | E-26.3% | n/a | ||
SOFTX | NOK 0.083 | -0.5% | 337.9% | NOK 187.2m | n/a | PS17.8x | n/a | n/a | ||
ONCIN | NOK 1.55 | 8.1% | n/a | NOK 161.3m | n/a | PS7.6x | n/a | n/a | ||
EXTX | NOK 1.90 | -15.2% | -63.5% | NOK 132.9m | n/a | PB1x | n/a | n/a | ||
ABS | NOK 3.75 | -5.1% | -72.6% | NOK 95.4m | n/a | PS2.2x | E126.9% | n/a | ||
CRNA | NOK 0.61 | -3.0% | -17.1% | NOK 67.2m | n/a | PE-10.1x | n/a | n/a | ||
BGBIO | NOK 1.22 | 2.4% | -87.8% | NOK 47.0m | n/a | PS8.8x | E-55.7% | n/a | ||
PCIB | NOK 0.35 | -13.4% | -81.2% | NOK 12.2m | n/a | PS2.8x | n/a | n/a |